// App-Quantinova.ai

SAT0088 (2018) : Predictive factors for interstitial lung disease progression in patients with rheumatoid arthritis: a role for biological inflammation and disease modified anti rheumatic drugs (DMARDS

Researchers

Presenter

  • C. Lucas

Principal Investigators

  • S. Jouneau

  • M. Lederlin

  • S. Guillot

  • C. Salliot

  • L. Joffres

  • E. Solau-Gervais

  • M. Herbette

  • A. Saraux

  • J.-B. Cren

  • B. Bouvard

  • J.-D. Albert

  • G. Coiffier

  • P. Guggenbuhl

  • A. Perdriger

Medical Centers

  • Rheumatology department, University Hospital Center

  • Rheumatology department, University Hospital Center

  • Radiology department

  • Rheumatology department, University Hospital Center

  • Rheumatology department, Hospital Center, Orléans

  • Rheumatology department, University Hospital Center

  • Rheumatology department, University Hospital Center

  • Rheumatology department, University Hospital Center, Angers, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

  • Interstitial lung disease

  • Rheumatoid arthritis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved